By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PDL BioPharma, Inc. 

Headquarters and R&D
1400 Seaport Boulevard
Redwood City  California  94063  U.S.A.
Phone: 650-454-1000 Fax: 650-454-2000



Company News
PDL BioPharma (PDLI) Announces The Successful Conclusion Of Its Debt Financing Agreement With Paradigm Spine, LLC 8/29/2016 8:41:01 AM
PDL BioPharma (PDLI) Announces Second Quarter 2016 Financial Results 8/5/2016 11:37:56 AM
PDL BioPharma (PDLI) Announces Elimination Of Quarterly Cash Dividend 8/5/2016 9:02:36 AM
PDL BioPharma (PDLI) Completes Second Tranche Payment Under Royalty Transaction With Ariad (ARIA) 8/2/2016 9:05:35 AM
PDL BioPharma (PDLI) To Announce Second Quarter 2016 Financial Results On August 4, 2016 7/28/2016 9:28:42 AM
PDL BioPharma (PDLI) Closes Equity Investment Transaction In Noden Pharma For The Acquisition Of Tekturna (Aliskiren) And Tekturna HCT (Aliskiren And Hydrochlorothiazide) 7/6/2016 6:25:48 AM
PDL BioPharma (PDLI) Completes Quarterly Dividend Payment 6/14/2016 1:12:12 PM
PDL BioPharma (PDLI) To Present At The Jefferies 2016 Healthcare Conference 6/1/2016 12:53:37 PM
PDL BioPharma (PDLI) Bags Novartis AG (NVS)'s Hypertension Drugs Via $107 Million Investment in Noden Pharma 5/25/2016 6:19:23 AM
PDL BioPharma (PDLI) Announces First Quarter 2016 Financial Results 5/5/2016 6:40:39 AM